Balyasny Asset Management’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
FMI
BIP
TAM
TRSOTSOK
IHAM
Balyasny Asset Management's FMS Position: Q1 2026 in Review
Balyasny Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 75,530 shares — an estimated $1.8M sold.
Balyasny Asset Management first reported a position in FMS in Q1 2018 and held it in 11 quarters. The position peaked at $16M in Q1 2023. 218 funds tracked by Wall St. Rank hold FMS as of Q1 2026.
- Balyasny Asset Management reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
- Balyasny Asset Management sold 75,530 Fresenius Medical Care shares in Q1 2026, an estimated $1.8M.
- Balyasny Asset Management first reported a position in Fresenius Medical Care in Q1 2018 and held it in 11 quarters.
- Balyasny Asset Management's Fresenius Medical Care position peaked at $16M in Q1 2023.
- 218 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.